Sanius Health key facts
as of Oct 2026- Developer of a healthcare platform designed to improve rare disease treatment and advance research into rare and chronic conditions.
- Sanius Health is valued at approximately $30.0M as of Oct 2026 (last reported valuation).
- It has raised $6.3M; the latest was Seed Round ($1.0M) in Sep 2025.
- Notable investors include Meltwind Advisory, Arāya Ventures.
- Status: Privately Held (backing).
Sanius Health's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·Watch Sanius Health: the Monday email on marks, rounds and moves
Sanius Health funding rounds
No funding rounds for Sanius Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Sanius Health
2Sanius Health valuation
Sanius Health's last reported valuation was $30 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Sanius Health investors
2 investors are on record for Sanius Health, including Meltwind Advisory and Arāya Ventures.
About Sanius Health
Developer of a healthcare platform designed to improve rare disease treatment and advance research into rare and chronic conditions. The company's approach to improving outcomes and access to new medicines focuses on combining live remote monitoring, patient genomics, secondary care, primary care, and patient-reported data, enabling patients to manage their well-being and improve their daily outcomes.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 26
- Website
- saniushealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.